The Food and Drug Administration (FDA) has accepted for review the resubmitted Biologics License Application (BLA) for prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025Company ...

Irish actor Colin Farrell recently finished the Dublin Marathon in 4:06:45, and he ran the last 2.5 miles while pushing his ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

Farrell pushed his friend with EB for the last 4 kilometers of the race, each kilometer representing a decade she has lived ...

Farrell got emotional as he completed the Dublin City Marathon with close friend Fogarty, in a bid to raise money for people with her rare genetic skin condition.

The Hollywood star said Emma Fogarty - who is Ireland's longest survivor with the genetic condition epidermolysis bullosa (EB ...

The 'Penguin' star and his friend Emma Fogarty, who has the skin condition epidermolysis bullosa (EB), raised over $850,000 ...

Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

“Epidermolysis bullosa is a devastating blistering skin disease that greatly impairs quality of life, particularly from the pain, itch, and risk of infection associated with open wounds. Evidence of ...